Search

Home > New FDA Approvals > 112 – Tildrakizumab-asmn for plaque psoriasis; clearance for molecular testing medium; 13-year-old boy receives gene therapy for blindness; FDA’s innovative methods for preventing illegal products entering US
Podcast: New FDA Approvals
Episode:

112 – Tildrakizumab-asmn for plaque psoriasis; clearance for molecular testing medium; 13-year-old boy receives gene therapy for blindness; FDA’s innovative methods for preventing illegal products entering US
Category: Science & Medicine
Duration: 00:10:09
Publish Date: 2018-03-22 07:00:00
Description:

March 22, 2018

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

1:18 Sun Pharma Announces U.S. FDA Approval of ILUMYA™ (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis https://www.prnewswire.com/news-releases/policy-public-interest-latest-news/fda-approval-list/

2:48 Longhorn Vaccines and Diagnostics LLC receives de novo clearance by the U.S. Food and Drug Administration for PrimeStore® Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing https://www.prnewswire.com/news-releases/policy-public-interest-latest-news/fda-approval-list/ 

4:47 13-Year-Old Boy Is First Person in US to Receive Newly Approved Gene Therapy for Blindness https://gizmodo.com/doctors-perform-breakthrough-fda-approved-gene-therapy-1823954611

7:01 FDA is using innovative methods to prevent illegal products with hidden drug ingredients from entering the United States https://blogs.fda.gov/fdavoice/index.php/2018/03/fda-is-using-innovative-methods-to-prevent-illegal-products-with-hidden-drug-ingredients-from-entering-the-united-states/

Brought to you by Nascent Medical. For assistance with medical writing, please email info@nascentmc.com.

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0